The easiest way to email your members of Congress
Donate Now
You are writing regarding
100% of users support H.R.1548
H.R.1548 has been viewed 16,938 times
H.R.1548 Pathway for Biosimilars Act, 111th Congress
Sponsor: Rep. Anna G. Eshoo [D, CA-18]Contact Congress
1.
Choose Your Position
2.
Write Your Letter
3.
Share Your Communication
OpenCongress Message Builder
OpenCongress Message Builder
Use the tools in this column to help craft your letter. Anytime your mouse highlights a section, click on it to add prepared text. You can edit any part of the message at left, and if you like, add your own stories and text to personalize your letter.
Official Bill Info
-
Latest Action: Mar 18, 2009
Referred to the Subcommittee on Health.
Clicking this will add the following text:
I know the most recent action for this bill is as follows: "Referred to the Subcommittee on Health." on Mar 18, 2009 -
Committee Assignment:
House Energy and Commerce
Clicking this will add the following text:
This bill has been assigned to the House Energy and Commerce committee. -
Committee Assignment:
House Judiciary
Clicking this will add the following text:
This bill has been assigned to the House Judiciary committee. -
Committee Assignment:
House Energy and Commerce - Health
Clicking this will add the following text:
This bill has been assigned to the House Energy and Commerce - Health committee.
Bill Statistics on OpenCongress
Clicking this will add the following text:
100% of users on OpenCongress.org, a free, non-partisan resource, support H.R.1548.
Clicking this will add the following text:
H.R.1548 has been viewed 16,938 times on OpenCongress.org, a free, non-partisan resource.
Contribution Data
Enter your street address above, and relevant campaign contribution data for your elected officials will appear here in seconds for you to use in your letter.
Supporting Organizations
-
Biotechnology Industry Organization
Clicking this will add the following text:
I know that the organization Biotechnology Industry Organization supports H.R.1548 -
California Healthcare Institute
Clicking this will add the following text:
I know that the organization California Healthcare Institute supports H.R.1548
Opposing Organizations
-
Generic Pharmaceutical Association
Clicking this will add the following text:
I know that the organization Generic Pharmaceutical Association opposes H.R.1548
Most-commented sections of the bill text
Highest Rated User Comments
Highly Rated Blog Articles
-
H.R.1548: Right to Rent Act of 2011 - U.S. Congress - OpenCongress
-
April 13, 2011
by
opencongress.org
-
Last week Raúl announced that he had reintroduced the Right to Rent Act of 2011 (H.R. 1548), an updated version of a bill he introduced in 2009 to allow families facing foreclosure to remain in their homes as ... Official government data, breaking news an
Clicking this will add the following text:
As noted by opencongress.org on April 13, 2011, "Last week Raúl announced that he had reintroduced the Right to Rent Act of 2011 (H.R. 1548), an updated version of a bill he introduced in 2009 to allow families facing foreclosure to remain in their homes as ... Official government data, breaking news an" (http://www.opencongress.org/bill/112-h1548/show) -
Policy Spotlight: Follow-On Biologics
-
December 19, 2010
by
child obesity problem
-
and HR 1548, also known as the ?Pathway for Biosimilars Act,? by Rep. Anna Eshoo (D ? Calif.), Jay Inslee (D-WA) and Joe Barton (R-TX). Chairman Waxman?s bill provides only three years of data exclusivity, with an additional two years ...
Clicking this will add the following text:
As noted by child obesity problem on December 19, 2010, "and HR 1548, also known as the ?Pathway for Biosimilars Act,? by Rep. Anna Eshoo (D ? Calif.), Jay Inslee (D-WA) and Joe Barton (R-TX). Chairman Waxman?s bill provides only three years of data exclusivity, with an additional two years ..." (http://childobesityproblem.blogspot.com/2010/12/policy-spotlight-follow-on-biologics.html) -
Patent Holders, Watch Out!
-
December 11, 2010
by
Digi Crunch Place
-
HR 1548 requires that a follow-on biologic candidate exhibits biosimilarity “based upon data derived from: reasonably studies that demonstrate that the organic product is highly correlative to the reference product, from beastly studies ...
Clicking this will add the following text:
As noted by Digi Crunch Place on December 11, 2010, "HR 1548 requires that a follow-on biologic candidate exhibits biosimilarity “based upon data derived from: reasonably studies that demonstrate that the organic product is highly correlative to the reference product, from beastly studies ..." (http://www.jagodina3.com/2010/12/patent-holders-watch-out/)
Highly Rated News Articles
We are trying to send your message

Contact Congress




